No black box warning on record for Galantamine Hydrobromide

As of the latest FDA labeling reviewed, Galantamine Hydrobromide (GALANTAMINE HYDROBROMIDE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Galantamine Hydrobromide medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Serious skin reactions: discontinue at first appearance of skin rash ( 5.1 ) All patients should be considered at risk for adverse effects on cardiac conduction, including bradycardia and AV block, due to vagotonic effects on sinoatrial and atrioventricular nodes ( 5.3 ) Active or occult gastrointestinal bleeding: monitor, especially those with an increased risk for deve

No black box warning on record for Galantamine Hydrobromide

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Serious skin reactions: discontinue at first appearance of skin rash ( 5.1 ) All patients should be considered at risk for adverse effects on cardiac conduction, including bradycardia and AV block, due to vagotonic effects on sinoatrial and atrioventricular nodes ( 5.3 ) Active or occult gastrointestinal bleeding: monitor, especially those with an increased risk for deve

Galantamine Hydrobromide Black Box Warning

No black box warning on record for Galantamine Hydrobromide

Other warnings & precautions

Galantamine Hydrobromide Black Box Warning

No black box warning on record for Galantamine Hydrobromide

Other warnings & precautions